title: Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat.
abstract: Endothelin (ET) 1 is a potent vasoactive peptide implicated in the pathogenesis of hypertension and renal disease. The aim of the current study was to test the hypotheses that ET-1 increases albumin permeability of glomeruli isolated from normal rats and that chronic ET-1 infusion will increase glomerular permeability and inflammation independent of blood pressure. Glomerular permeability to albumin was determined from the change in glomerular volume induced by exposing isolated glomeruli to oncotic gradients. Incubation of glomeruli taken from normal rats with ET-1 at a concentration that did not produce direct glomerular contraction (1 nmol/L) significantly increased glomerular permeability to albumin, reaching a maximum after 4 hours. Chronic ET-1 infusion for 2 weeks in Sprague-Dawley rats significantly increased glomerular permeability to albumin and nephrin excretion rate, effects that were attenuated in rats given an ET(A) receptor antagonist (ABT-627, 5 mg/kg per day). Urinary protein and albumin excretion and mean arterial pressure (telemetry) were not changed by ET-1 infusion. Acute incubation of glomeruli isolated from ET-1-infused rats with the selective ET(A) antagonist significantly reduced glomerular permeability to albumin, an effect not observed with acute treatment with a selective ET(B) antagonist. Chronic ET-1 infusion increased glomerular and plasma soluble intercellular adhesion molecule 1 and monocyte chemoattractant protein 1 and elevated the number of macrophages and lymphocytes in renal cortices (ED-1 and CD3-positive staining, respectively). These effects were all attenuated in rats given an ET(A) selective antagonist. These data support the hypothesis that ET-1 directly increases glomerular permeability to albumin and renal inflammation via ET(A) receptor activation independent of changes in arterial pressure.
authors.affiliation: Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912-2500, USA.
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Saleh
authors.forename: Erika I
authors.initials: EI
authors.lastname: Boesen
authors.forename: Jennifer S
authors.initials: JS
authors.lastname: Pollock
authors.forename: Virginia J
authors.initials: VJ
authors.lastname: Savin
authors.forename: David M
authors.initials: DM
authors.lastname: Pollock
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000077868:Atrasentan; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1 / Q000378:metabolism* / Q000494:pharmacology; D007118:Immunoassay; D007150:Immunohistochemistry; D007249:Inflammation / Q000378:metabolism*; D007678:Kidney Glomerulus / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D010539:Permeability / Q000187:drug effects; D011759:Pyrrolidines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017466:Receptors, Endothelin / Q000378:metabolism*
chemical_list: D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1; D011759:Pyrrolidines; D017466:Receptors, Endothelin; D000077868:Atrasentan
references.citation: Diabetologia. 1995 Oct;38(10):1197-204
references.pmid: 8690172
references.citation: Diabetes. 2003 Apr;52(4):1023-30
references.pmid: 12663475
references.citation: Am J Physiol. 1978 Aug;235(2):F142-50
references.pmid: 686177
references.citation: Diabetes. 2001 Nov;50(11):2619-24
references.pmid: 11679443
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7962-7
references.pmid: 10393930
references.citation: Kidney Int. 1997 Mar;51(3):770-6
references.pmid: 9067909
references.citation: J Lab Clin Med. 1996 Sep;128(3):297-303
references.pmid: 8783637
references.citation: Am J Physiol. 1995 Mar;268(3 Pt 2):F455-60
references.pmid: 7900845
references.citation: Nephron. 2001 Feb;87(2):161-9
references.pmid: 11244312
references.citation: Hypertension. 2009 Jul;54(1):113-9
references.pmid: 19506099
references.citation: Hypertens Res. 2004 Jul;27(7):493-500
references.pmid: 15302986
references.citation: J Am Soc Nephrol. 2007 Apr;18(4):1353-61
references.pmid: 17329575
references.citation: Am J Physiol Renal Physiol. 2008 May;294(5):F1185-94
references.pmid: 18287402
references.citation: J Hypertens. 2004 Jan;22(1):111-9
references.pmid: 15106802
references.citation: Cardiovasc Res. 2006 Jul 1;71(1):61-8
references.pmid: 16580653
references.citation: J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S467-70
references.pmid: 15838350
references.citation: Am J Pathol. 2005 May;166(5):1309-20
references.pmid: 15855633
references.citation: Hypertension. 1992 Jun;19(6 Pt 2):676-80
references.pmid: 1592467
references.citation: Transplantation. 2002 Feb 15;73(3):366-72
references.pmid: 11884932
references.citation: J Clin Invest. 1990 Mar;85(3):790-7
references.pmid: 2155927
references.citation: Am J Kidney Dis. 1997 Jan;29(1):2-26
references.pmid: 9002526
references.citation: Biochem Biophys Res Commun. 1994 Mar 30;199(3):1461-5
references.pmid: 8147891
references.citation: J Hypertens. 2008 Jun;26(6):1102-9
references.pmid: 18475147
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: J Am Soc Nephrol. 2007 Jan;18(1):143-54
references.pmid: 17167119
references.citation: J Clin Invest. 1997 Mar 15;99(6):1380-9
references.pmid: 9077548
references.citation: Am J Pathol. 1981 Nov;105(2):114-20
references.pmid: 6457533
references.citation: Hypertension. 2003 Oct;42(4):806-10
references.pmid: 12874096
references.citation: J Am Soc Nephrol. 2006 Apr;17(4):1082-9
references.pmid: 16495378
references.citation: Hypertension. 2005 Feb;45(2):283-7
references.pmid: 15623539
references.citation: Hypertension. 1996 Aug;28(2):196-201
references.pmid: 8707381
references.citation: Kidney Int. 2006 Jan;69(1):73-80
references.pmid: 16374426
references.citation: Am J Clin Pathol. 1972 Aug;58(2):135-9
references.pmid: 5047603
references.citation: Mol Cell Biol. 2007 Dec;27(24):8698-712
references.pmid: 17923684
references.citation: J Am Soc Nephrol. 2009 Mar;20(3):655-64
references.pmid: 19144760
references.citation: J Am Soc Nephrol. 1992 Dec;3(6):1260-9
references.pmid: 1477322
references.citation: Am J Pathol. 2006 Dec;169(6):1965-75
references.pmid: 17148661
references.citation: Hypertens Res. 2004 Jun;27(6):433-40
references.pmid: 15253109
references.citation: Kidney Int. 1993 Jul;44(1):36-42
references.pmid: 8355464
references.citation: Diabetes. 1997 Dec;46(12):2075-81
references.pmid: 9392499